Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
27.08.24 | Actinogen Medical - Further positive XanaCIDD results on depression | 346 | Edison Investment Research | New data were revealed from Actinogen Medical's ongoing analysis of the now-completed XanaCIDD study that support the view that the company's lead drug candidate, Xanamem, may provide consistent and... ► Artikel lesen | |
27.08.24 | Mendus - Broad progress across the pipeline | 247 | Edison Investment Research | Mendus's Q224 results reflect a period of steady progress across its clinical programmes. For vididencel, the Phase II CADENCE trial (for acute myeloid leukaemia, AML) is now ready to commence patient... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.956 |
TESLA | 2.160 |
STEYR MOTORS | 2.125 |
DEUTZ | 1.994 |
RENK GROUP | 1.905 |
TUI | 1.796 |
THYSSENKRUPP | 1.575 |
RHEINMETALL | 1.565 |
NEL | 1.448 |
BYD | 1.429 |
BAYER | 1.128 |
EVOTEC | 996 |
NOVO NORDISK | 981 |
DEUTSCHE BANK | 887 |
XIAOMI | 853 |
COMMERZBANK | 795 |
BASF | 794 |
VOLKSWAGEN | 781 |
MERCEDES-BENZ | 723 |
AIXTRON SE | 693 |
PORSCHE AG | 674 |
PUMA | 674 |
HENSOLDT | 651 |
BARRICK GOLD | 636 |
MUTARES | 632 |